Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The LTI-01-2001 phase 2a trial of intrapleural LTI-01 in patients with infected, non-draining pleural effusions.

Respiratory research·2026

Same author

Improved reachability during bronchoscopy with a novel multisection robotic bronchoscope.

JTCVS techniques·2026

Same author

Evolution of Diagnostic Yield for Peripheral Lung Nodule Biopsies With Changes in Navigational Bronchoscopy Platforms, Tools, and Intraoperative Imaging Guidance.

Journal of bronchology & interventional pulmonology·2026

Same author

Consensus-based standardization of procedural steps for indwelling pleural catheter placement: a modified Delphi study.

Expert review of respiratory medicine·2025

Same author

Prone positioning in cone beam CT-guided robotic bronchoscopy case series: a strategy to minimize atelectasis and improve access to posteromedial lower lobe nodules.

Journal of thoracic disease·2025

Same author

Safety and feasibility of bronchoscopic microwave ablation technology for peripheral lung cancer: a multi-center, prospective, single-arm study protocol.

BMC surgery·2025

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Nonresolving pneumonia.

Fayez Kheir¹, Tamim Hamdi, Walid Khayr

¹Department of Medicine, Chicago Medical School/Rosalind Franklin, University of Medicine and Science, Chicago, IL, USA. fmk01@hotmail.com

American Journal of Therapeutics

|May 12, 2010

Summary

A rare lung infection, pulmonary actinomycosis, was diagnosed in a patient with persistent pneumonia symptoms. Early recognition is crucial to prevent severe complications from this challenging bacterial disease.

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Related Experiment Videos

Last Updated: Jun 13, 2026

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Area of Science:

Pulmonology
Infectious Diseases
Microbiology

Background:

Pulmonary actinomycosis is a rare bacterial infection caused by Actinomyces species.
It often presents with non-specific symptoms, mimicking other respiratory conditions like pneumonia.

Observation:

A 58-year-old man presented with weight loss and dry cough, initially diagnosed with community-acquired pneumonia.
Despite antibiotic treatment, his condition worsened, requiring intubation and further investigation.

Findings:

Fiber optic bronchoscopy revealed significant mucopurulent secretions.
Bronchoalveolar lavage identified sulfur granules, and cultures confirmed Actinomyces israelii.

Implications:

This case highlights the diagnostic challenges of pulmonary actinomycosis.
Timely diagnosis and appropriate treatment are essential to avoid severe complications.